These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15887857)

  • 21. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sporadic primary hyperparathyroidism and stone disease: a comprehensive metabolic evaluation before and after parathyroidectomy.
    Marchini GS; Faria KVM; Torricelli FCM; Monga M; Srougi M; Nahas WC; Mazzucchi E
    BJU Int; 2018 Feb; 121(2):281-288. PubMed ID: 29124877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism.
    Broadus AE; Horst RL; Lang R; Littledike ET; Rasmussen H
    N Engl J Med; 1980 Feb; 302(8):421-6. PubMed ID: 7351950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of renal function in primary hyperparathyroidism.
    Walker MD; Nickolas T; Kepley A; Lee JA; Zhang C; McMahon DJ; Silverberg SJ
    J Clin Endocrinol Metab; 2014 May; 99(5):1885-92. PubMed ID: 24527717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can 24-hour urine stone risk profiles predict urinary stone composition?
    Torricelli FC; De S; Liu X; Calle J; Gebreselassie S; Monga M
    J Endourol; 2014 Jun; 28(6):735-8. PubMed ID: 24460026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NEPHROLITHIASIS IN PRIMARY HYPERPARATHYROIDISM: A COMPARISON BETWEEN SILENT AND SYMPTOMATIC PATIENTS.
    Castellano E; Attanasio R; Latina A; Visconti GL; Cassibba S; Borretta G
    Endocr Pract; 2017 Feb; 23(2):157-162. PubMed ID: 27819765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with primary hyperparathyroidism--why do some form stones?
    Berger AD; Wu W; Eisner BH; Cooperberg MR; Duh QY; Stoller ML
    J Urol; 2009 May; 181(5):2141-5. PubMed ID: 19296981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of blood tests in screening for metabolic disorders in kidney stone disease.
    Eyre KS; Lewis F; Cui H; Grout E; Mihai R; Turney BW; Howles SA
    BJU Int; 2021 May; 127(5):538-543. PubMed ID: 32967050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Crohn's disease and kidney stones: much more than coincidence?].
    Viana ML; Pontes RM; Garcia WE; Fávero ME; Prete DC; Matsuo T
    Arq Gastroenterol; 2007; 44(3):210-4. PubMed ID: 18060273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multiregional Italian cohort of 24-hour urine metabolic evaluation in renal stone formers.
    Esperto F; Marangella M; Trinchieri A; Petrarulo M; Miano R
    Minerva Urol Nefrol; 2018 Feb; 70(1):87-94. PubMed ID: 28882031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic assessment of recurrent and first renal calcium oxalate stone formers.
    Çakıroğlu B; Eyyupoğlu E; Hazar AI; Uyanik BS; Nuhoğlu B
    Arch Ital Urol Androl; 2016 Jul; 88(2):101-5. PubMed ID: 27377084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of hypercalciuria after successful surgical treatment for primary hyperparathyroidism.
    Spivacow FR; Negri AL; del Valle EE; Fradinger E; Martinez C; Polonsky A
    Int Urol Nephrol; 2012 Jun; 44(3):857-63. PubMed ID: 21505756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of kidney stone composition in the detection of metabolic abnormalities.
    Pak CY; Poindexter JR; Adams-Huet B; Pearle MS
    Am J Med; 2003 Jul; 115(1):26-32. PubMed ID: 12867231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quantitative mineralogical analyzes of kidney stones and diagnosing metabolic disorders in female patients with calcium oxalate urolithiasis].
    Kustov AV; Moryganov MA; Strel'nikov AI; Zhuravleva NI; Airapetyan AO
    Urologiia; 2016 Feb; (1):11-15. PubMed ID: 28247696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephrolithiasis and renal calcifications in primary hyperparathyroidism.
    Rejnmark L; Vestergaard P; Mosekilde L
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2377-85. PubMed ID: 21646371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.